O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-10.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.91B
AUM Growth
+$5.91B
(-15%)
Cap. Flow
-$46.9M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
34.46%
Holding
169
New
32
Increased
33
Reduced
28
Closed
26
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$139M |
| 2 |
Biogen
BIIB
|
$132M |
| 3 |
Passage Bio
PASG
|
$110M |
| 4 |
Pfizer
PFE
|
$98.3M |
| 5 |
Gilead Sciences
GILD
|
$85.6M |
Top Sells
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$372M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$99.8M |
| 3 |
Danaher
DHR
|
$98.1M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$93.8M |
| 5 |
Tandem Diabetes Care
TNDM
|
$68M |
Sector Composition
| 1 | Healthcare | 97.58% |
| 2 | Financials | 1.89% |
